ORKA PB Ratio
4.20×TTM
Retrieved:
ORKA FY P/B Ratio
11.02×-1.23×
2005-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
ORKA pb ratio history
Price-to-book ratio. The available annual fiscal periods series contains 21 observations from Dec 31, 2005 to Dec 31, 2025.
| Period ending | PB Ratio |
|---|---|
| 2.9296× | |
| 0.8517× | |
| 7.9439× | |
| 9.8343× | |
| 7.0278× | |
| 4.8721× | |
| 0.9914× | |
| 0.7576× | |
| 1.3705× | |
| 1.1644× | |
| 0.7682× | |
| 1.3212× | |
| 0.9304× | |
| 1.7432× | |
| 1.7505× | |
| 3.9839× | |
| 3.1203× | |
| -0.0442× | |
| 1.4428× | |
| 2.9511× | |
| 5.9104× |
Compare pb ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) pb ratio
- Bridgebio Pharma Inc (BBIO) pb ratio
- Brightspring Health Services Inc (BTSG) pb ratio
- Madrigal Pharmaceuticals Inc (MDGL) pb ratio
- Ensign Group Inc (ENSG) pb ratio
- Glaukos Corp (GKOS) pb ratio
- Vaxcyte Inc (PCVX) pb ratio
- Krystal Biotech Inc (KRYS) pb ratio
Compare all covered stocks by pb ratio →
All ORKA financial metrics · ORKA stock overview · How to interpret financial metrics